Hereditary pyrimidine 5'-nucleotidase deficiency: from genetics to clinical manifestations

British Journal of Haematology
Alberto ZanellaGiovanna Valentini

Abstract

Hereditary pyrimidine 5'-nucleotidase (P5'N) deficiency is the most frequent abnormality of the red cell nucleotide metabolism causing hereditary non-spherocytic haemolytic anaemia. The disorder is usually characterised by mild-to-moderate haemolytic anaemia associated with the accumulation of high concentrations of pyrimidine nucleotides within the erythrocyte. The precise mechanisms leading to the destruction of P5'N deficient red cells are still unclear. The pyrimidine 5'-nucleotidase type-I (P5'N-1) gene is localised on 7p15-p14 and the cDNA has been cloned and sequenced; 20 mutations have been identified so far in 30 unrelated families, most of them at the homozygous level. Recently, the comparison of recombinant mutants of human P5'N-1 with the wild-type enzyme has enabled the effects of amino acid replacements on the enzyme molecular properties to be determined and help to correlate genotype to clinical phenotype.

References

Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·J D TorranceE Beutler
Jul 2, 1979·Clinica Chimica Acta; International Journal of Clinical Chemistry·H BucA Najman
Apr 17, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·H Buc, J C Kaplan
Aug 15, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·P H EllimsM B Van der Weyden
Apr 1, 1977·The Journal of Pediatrics·S E SnydermanS V Phansalkar
Jul 15, 1992·The Biochemical Journal·H Zimmermann
Sep 1, 1987·American Journal of Hematology·T KondoS Miwa
Dec 1, 1985·Analytical Biochemistry·C R Zerez, K R Tanaka
Aug 1, 1986·British Journal of Haematology·N A Lachant, K R Tanaka
Jan 1, 1985·The American Journal of Cardiology·G J BaladyT J Ryan
Oct 1, 1974·The Journal of Clinical Investigation·W N ValentineW S Adams
Oct 31, 1983·Clinica Chimica Acta; International Journal of Clinical Chemistry·A EricsonM Seip
Jan 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D E PagliaR A Brockway
Mar 1, 1984·British Journal of Haematology·J L Vives CorronsA Ester
Jan 1, 1984·International Journal of Immunopharmacology·M Halonen, M Kaliner
Nov 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·T KondoE Beutler
Mar 1, 1993·British Journal of Haematology·Alberto ZanellaG Barosi
Jun 11, 1998·The Journal of Biological Chemistry·J F ColletE Van Schaftingen
Jul 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·C RampazzoVera Bianchi
Aug 5, 2000·Baillière's Best Practice & Research. Clinical Haematology·J L Vives i Corrons
Jan 13, 2001·The Journal of Biological Chemistry·Sally Anne HunsuckerB S Mitchell
Jul 4, 2001·The Journal of Biological Chemistry·S AllegriniM G Tozzi
Aug 3, 2001·Blood Cells, Molecules & Diseases·Alberto ZanellaM Sampietro
Sep 28, 2002·Nature Structural Biology·Agnes Rinaldo-MatthisPär Nordlund
Feb 13, 2003·British Journal of Haematology·D C ReesA M Marinaki
Aug 22, 2003·British Journal of Haematology·Paola BianchiAlberto Zanella
Aug 30, 2003·The Journal of Biological Chemistry·Vera Bianchi, Jozef Spychala
Jul 9, 2004·British Journal of Haematology·Hitoshi KannoHisaichi Fujii
Dec 2, 2004·Nucleosides, Nucleotides & Nucleic Acids·E EscuredoD C Rees
Jun 21, 2005·Pharmacology & Therapeutics·Sally Anne HunsuckerJozef Spychala
Jun 22, 2005·Cellular and Molecular Life Sciences : CMLS·A AmiciG Magni
Jun 29, 2005·British Journal of Haematology·Alberto ZanellaGiovanna Valentini
Jan 21, 2006·Acta Haematologica·E Parisi-DuchêneP Moskovtchenko
Mar 22, 2006·Acta Haematologica·Marilyn J Manco-Johnson
Nov 25, 2006·Hematology·Laurie H Sehn
Nov 25, 2006·Hematology·Paula L Bockenstedt
Mar 1, 1991·TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·R L Harcourt, M D Gale

Citations

Sep 6, 2007·Journal of Structural and Functional Genomics·George N PhillipsSimon N Twigger
Dec 12, 2012·The Journal of Biological Chemistry·Juliane BuschmannElmar Wahle
Oct 17, 2013·Biochimica Et Biophysica Acta·Benjamin A Barasa, Monique Slijper
May 23, 2012·The FEBS Journal·Annegrit SeifriedAntje Gohla
Aug 29, 2012·Journal of Molecular Biology·Christina L GroboskyEduard Bitto
Dec 10, 2013·Free Radical Biology & Medicine·Rob van ZwietenDirk Roos
Jul 7, 2016·Proteomics. Clinical Applications·Benjamin A BarasaMonique Slijper
Jun 19, 2018·Frontiers in Physiology·Rick HuisjesRichard van Wijk
May 10, 2019·International Journal of Laboratory Hematology·Anton RetsArchana M Agarwal
Jul 14, 2020·Frontiers in Immunology·Anna ZaninoniPaola Bianchi
Feb 25, 2019·European Journal of Medicinal Chemistry·Rémi GuillonSuzanne Peyrottes

Related Concepts

Anemia, Hemolytic, Congenital
Structure-Activity Relationship
5'-NUCLEOTIDASE

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.